HLA-DRB1*15 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis

被引:29
作者
Imrell, Kerstin [1 ]
Greiner, Eva [1 ]
Hillert, Jan [1 ]
Masterman, Thomas [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Div Neurol, S-14186 Huddinge, Sweden
基金
瑞典研究理事会;
关键词
Age of onset; HLA-DRB1*15 antigen; Multiple sclerosis; Oligoclonal bands; Prognosis; Survival analysis; FOLLOW-UP; DISABILITY; DIAGNOSIS; SEVERITY; HLA-DR15;
D O I
10.1016/j.jneuroim.2009.03.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Carriage of HLA-DRB1*15 is the most important genetic risk factor in multiple sclerosis (MS), while CSF-specific oligoclonal immunoglobulin G bands (CCB) constitute the most sensitive biochemical marker for diagnosing MS. We demonstrated in an earlier study the interdependence of HLA-DRB1 genotype and CCB status; the effect of these phenotypic features on MS prognosis remains controversial, however. We investigated by survival analysis the impact of each variable on age at two important MS milestones: onset of clinical symptoms and an Expanded Disability Status Scale (EDSS) score of 6.0. Both carriage of HLA-DRB1*15 and the presence of OCB hastened attainment of EDSS 6.0. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:128 / 130
页数:3
相关论文
共 20 条
[1]   Clinical outcome measures in multiple sclerosis [J].
Amato, Maria Pia ;
Portaccio, Emilio .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 259 (1-2) :118-122
[2]   CEREBROSPINAL-FLUID IN THE DIAGNOSIS OF MULTIPLE-SCLEROSIS - A CONSENSUS REPORT [J].
ANDERSSON, M ;
ALVAREZCERMENO, J ;
BERNARDI, G ;
COGATO, I ;
FREDMAN, P ;
FREDERIKSEN, J ;
FREDRIKSON, S ;
GALLO, P ;
GRIMALDI, LM ;
GRONNING, M ;
KEIR, G ;
LAMERS, K ;
LINK, H ;
MAGALHAES, A ;
MASSARO, AR ;
OHMAN, S ;
REIBER, H ;
RONNBACK, L ;
SCHLUEP, M ;
SCHULLER, E ;
SINDIC, CJM ;
THOMPSON, EJ ;
TROJANO, M ;
WURSTER, U .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (08) :897-902
[3]   Age at disability milestones in multiple sclerosis [J].
Confavreux, C ;
Vukusic, S .
BRAIN, 2006, 129 :595-605
[4]   An extremes of outcome strategy provides evidence that multiple sclerosis is determined by alleles at the HLA-DRB1 locus [J].
DeLuca, G. C. ;
Ramagopalan, S. V. ;
Herrera, B. M. ;
Dymentt, D. A. ;
Lincoln, M. R. ;
Montpetit, A. ;
Pugliattill, M. ;
Barnardo, M. C. N. ;
Risch, N. J. ;
Sadovnick, A. D. ;
Chao, M. ;
Sotgiu, S. ;
Hudson, T. J. ;
Ebers, G. C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20896-20901
[5]   'Subclinical MS': follow-up of four cases [J].
Hakiki, B. ;
Goretti, B. ;
Portaccio, E. ;
Zipoli, V. ;
Amato, M. P. .
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (08) :858-861
[6]   Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct [J].
Imrell, Kerstin ;
Landtblom, Anne-Marie ;
Hillert, Jan ;
Masterman, Thomas .
NEUROLOGY, 2006, 67 (06) :1062-1064
[7]   Epidemiology and natural history of multiple sclerosis: new insights [J].
Kantarci, Orhun ;
Wingerchuk, Dean .
CURRENT OPINION IN NEUROLOGY, 2006, 19 (03) :248-254
[8]  
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[9]   Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile [J].
Lebrun, C. ;
Bensa, C. ;
Debouverie, M. ;
De Seze, J. ;
Wiertlievski, S. ;
Brochet, B. ;
Clavelou, P. ;
Brassat, D. ;
Labauge, P. ;
Roullet, E. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (02) :195-198
[10]  
Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO